2007年，FDA在经过多因素分析后要求在文迪雅的标签上做出警示，提示患者文迪雅将会增加心脏病发作和心血管疾病死亡的风险。
In 2007, the FDA slapped a warning on Avandia's label after a meta-analysis showed that users faced an increased risk of heart attack and death from cardiovascular problems.
2007年，FDA在经过多因素分析后要求在文迪雅的标签上做出警示，提示患者文迪雅将会增加心脏病发作和心血管疾病死亡的风险。
In 2007, the FDA slapped a warning on Avandia's label after a meta-analysis showed that users faced an increased risk of heart attack and death from cardiovascular problems.
应用推荐